PCR-restriction enzyme analysis for detection of Candida DNA in blood from febrile patients with hematological malignancies.

PubWeight™: 1.12‹?› | Rank: Top 10%

🔗 View Article (PMC 84973)

Published in J Clin Microbiol on June 01, 1999

Authors

G Morace1, L Pagano, M Sanguinetti, B Posteraro, L Mele, F Equitani, G D'Amore, G Leone, G Fadda

Author Affiliations

1: Institutes of Microbiologia, Facoltà di Medicina e Chirurgia "A. Gemelli," Università Cattolica del Sacro Cuore, 1-00168 Rome, Italy. morace@imiucca.csi.unimi.it

Articles citing this

Combination antifungal therapy. Antimicrob Agents Chemother (2004) 3.49

Rapid identification of pathogenic fungi directly from cultures by using multiplex PCR. J Clin Microbiol (2002) 2.31

Seminested PCR for diagnosis of candidemia: comparison with culture, antigen detection, and biochemical methods for species identification. J Clin Microbiol (2002) 1.60

Current status of nonculture methods for diagnosis of invasive fungal infections. Clin Microbiol Rev (2002) 1.59

PCR diagnosis of invasive candidiasis: systematic review and meta-analysis. J Clin Microbiol (2010) 1.59

Bench-to-bedside review: Candida infections in the intensive care unit. Crit Care (2008) 1.49

Rapid identification of Candida dubliniensis using a species-specific molecular beacon. J Clin Microbiol (2000) 1.34

Rapid identification of yeasts in positive blood cultures by a multiplex PCR method. J Clin Microbiol (2001) 1.27

PCR-based diagnosis of human fungal infections. Expert Rev Anti Infect Ther (2009) 1.24

High-throughput identification of clinical pathogenic fungi by hybridization to an oligonucleotide microarray. J Clin Microbiol (2006) 1.14

Comparison of non-culture-based methods for detection of systemic fungal infections, with an emphasis on invasive Candida infections. J Clin Microbiol (2005) 1.13

Rapid identification of yeasts commonly found in positive blood cultures by amplification of the internal transcribed spacer regions 1 and 2. Eur J Clin Microbiol Infect Dis (2003) 0.93

Reverse cross blot hybridization assay for rapid detection of PCR-amplified DNA from candida species, Cryptococcus neoformans, and Saccharomyces cerevisiae in clinical samples. J Clin Microbiol (2000) 0.88

Invasive fungal infections in patients with cancer in the Intensive Care Unit. Int J Antimicrob Agents (2012) 0.86

Canadian clinical practice guidelines for invasive candidiasis in adults. Can J Infect Dis Med Microbiol (2010) 0.82

Neonatal candidiasis: diagnosis, prevention, and treatment. J Infect (2014) 0.78

The diagnosis of hepatosplenic candidiasis by DNA analysis of tissue biopsy and serum. J Clin Pathol (2004) 0.76

Articles cited by this

Clinical, cellular, and molecular factors that contribute to antifungal drug resistance. Clin Microbiol Rev (1998) 9.76

Detection and identification of fungal pathogens in blood by using molecular probes. J Clin Microbiol (1997) 5.86

Candidemia in a tertiary care hospital: epidemiology, risk factors, and predictors of mortality. Clin Infect Dis (1992) 4.98

Epidemiology of nosocomial fungal infections, with emphasis on Candida species. Clin Infect Dis (1995) 3.69

Fungal infections in cancer patients: an international autopsy survey. Eur J Clin Microbiol Infect Dis (1992) 3.16

Detection of surgical pathogens by in vitro DNA amplification. Part I. Rapid identification of Candida albicans by in vitro amplification of a fungus-specific gene. Surgery (1990) 2.93

Polymerase chain reaction for the diagnosis of candidemia. J Infect Dis (1993) 2.62

Rapid identification of Candida species in blood cultures by a clinically useful PCR method. J Clin Microbiol (1997) 2.46

Risk factors for fungal infection in patients with malignant hematologic disorders: implications for empirical therapy and prophylaxis. Clin Infect Dis (1994) 2.41

Rapid detection and identification of Candida albicans and Torulopsis (Candida) glabrata in clinical specimens by species-specific nested PCR amplification of a cytochrome P-450 lanosterol-alpha-demethylase (L1A1) gene fragment. J Clin Microbiol (1994) 2.15

Detection of Candida albicans and other yeasts in blood by PCR. J Clin Microbiol (1994) 2.13

Improved detection of Candida albicans by PCR in blood of neutropenic mice with systemic candidiasis. J Clin Microbiol (1995) 1.93

Nonculture methods for diagnosis of disseminated candidiasis. Clin Microbiol Rev (1993) 1.88

Clinical comparison of isolator and BACTEC 660 resin media for blood culture. J Clin Microbiol (1990) 1.51

Candidemia in immunocompromised patients. Clin Infect Dis (1992) 1.45

Candida krusei fungemia. Report of 4 cases and review of the literature. Medicine (Baltimore) (1993) 1.44

Vascular catheter-associated fungemia in patients with cancer: analysis of 155 episodes. Clin Infect Dis (1992) 1.42

Identification of various medically important Candida species in clinical specimens by PCR-restriction enzyme analysis. J Clin Microbiol (1997) 1.27

Detection of candidemia by polymerase chain reaction. Mol Cell Probes (1994) 1.20

Fungemia in patients with leukemia. Am J Med Sci (1993) 1.19

Detection of Candida antigenuria in disseminated candidiasis by immunoblotting. J Clin Microbiol (1990) 1.07

Invasive fungal disease in adults undergoing remission-induction therapy for acute myeloid leukemia: the pathogenetic role of the antileukemic regimen. Clin Infect Dis (1995) 1.03

Polymerase chain reaction and restriction fragment length polymorphism mediated detection and speciation of Candida spp causing intraocular infection. Invest Ophthalmol Vis Sci (1998) 1.02

Hepatosplenic yeast infection in patients with acute leukemia: a diagnostic problem. Clin Infect Dis (1994) 0.94

Improved survival from fungaemia in patients with haematological malignancies: analysis of risk factors for death and usefulness of early antifungal therapy. Eur J Haematol (1993) 0.92

Polymerase chain reaction used to detect candidemia in patients with candiduria. Urology (1998) 0.86

Successful treatment of hepatosplenic candidiasis through repeated cycles of chemotherapy and neutropenia. Cancer (1995) 0.83

Lethal infections in patients with hematological malignancies. Eur J Haematol (1993) 0.81

Bacteraemia and fungaemia in an Australian general hospital--associations and outcomes. Med J Aust (1993) 0.78

Management of the cancer patient with fever and prolonged neutropenia. Hematol Oncol Clin North Am (1993) 0.78

Articles by these authors

Ecology. Synthesizing U.S. river restoration efforts. Science (2005) 7.26

Distinct roles for E2F proteins in cell growth control and apoptosis. Proc Natl Acad Sci U S A (1997) 5.83

Role for E2F in control of both DNA replication and mitotic functions as revealed from DNA microarray analysis. Mol Cell Biol (2001) 5.03

Impact of vitamin A supplementation on childhood mortality. A randomised controlled community trial. Lancet (1986) 4.89

Neurodevelopmental and functional outcomes of extremely low birth weight infants in the National Institute of Child Health and Human Development Neonatal Research Network, 1993-1994. Pediatrics (2000) 4.49

The E2F1-3 transcription factors are essential for cellular proliferation. Nature (2001) 4.37

Vitamin A supplementation for extremely-low-birth-weight infants. National Institute of Child Health and Human Development Neonatal Research Network. N Engl J Med (1999) 3.11

Ras enhances Myc protein stability. Mol Cell (1999) 2.91

ESCMID and ECMM joint clinical guidelines for the diagnosis and management of mucormycosis 2013. Clin Microbiol Infect (2014) 2.47

The accumulation of an E2F-p130 transcriptional repressor distinguishes a G0 cell state from a G1 cell state. Mol Cell Biol (1996) 2.47

Cdc6 is regulated by E2F and is essential for DNA replication in mammalian cells. Proc Natl Acad Sci U S A (1998) 2.40

Zygomycosis in Europe: analysis of 230 cases accrued by the registry of the European Confederation of Medical Mycology (ECMM) Working Group on Zygomycosis between 2005 and 2007. Clin Microbiol Infect (2011) 2.38

Evaluation of BACTEC Mycobacteria Growth Indicator Tube (MGIT 960) automated system for drug susceptibility testing of Mycobacterium tuberculosis. J Clin Microbiol (2001) 2.34

Sildenafil increases cerebrovascular reactivity: a transcranial Doppler study. Neurology (2005) 2.18

Analysis of the microtopography of the skin by silicone replicas after repeated exposure to actinic radiation at high altitudes. J Eur Acad Dermatol Venereol (2001) 2.04

Reprogramming of the tumour microenvironment by stromal PTEN-regulated miR-320. Nat Cell Biol (2011) 1.98

Office normotensives with a minimal augmentation of intima-media thickness of common carotid arteries: really normotensives? Eur Rev Med Pharmacol Sci (2013) 1.97

The risk of recurrent deep venous thrombosis among heterozygous carriers of both factor V Leiden and the G20210A prothrombin mutation. N Engl J Med (1999) 1.97

E2F1-specific induction of apoptosis and p53 accumulation, which is blocked by Mdm2. Cell Growth Differ (1998) 1.96

E2F-1 accumulation bypasses a G1 arrest resulting from the inhibition of G1 cyclin-dependent kinase activity. Genes Dev (1995) 1.95

Fungal infections in recipients of hematopoietic stem cell transplants: results of the SEIFEM B-2004 study--Sorveglianza Epidemiologica Infezioni Fungine Nelle Emopatie Maligne. Clin Infect Dis (2007) 1.94

Recovery and susceptibility testing of Mycobacterium tuberculosis from extrapulmonary specimens by the BACTEC radiometric method. J Clin Microbiol (1984) 1.93

Inhibition of constitutive and BCR-induced Syk activation downregulates Mcl-1 and induces apoptosis in chronic lymphocytic leukemia B cells. Leukemia (2008) 1.92

The Akt signaling pathway determines the different proliferative capacity of chronic lymphocytic leukemia B-cells from patients with progressive and stable disease. Leukemia (2006) 1.92

Occurrence of extended-spectrum beta-lactamases in members of the family Enterobacteriaceae in Italy: implications for resistance to beta-lactams and other antimicrobial drugs. Antimicrob Agents Chemother (2002) 1.88

Expression of the HsOrc1 gene, a human ORC1 homolog, is regulated by cell proliferation via the E2F transcription factor. Mol Cell Biol (1996) 1.83

Fatal pulmonary infection due to multidrug-resistant Mycobacterium abscessus in a patient with cystic fibrosis. J Clin Microbiol (2001) 1.83

An EORTC multicentre prospective survey of invasive aspergillosis in haematological patients: diagnosis and therapeutic outcome. EORTC Invasive Fungal Infections Cooperative Group. J Infect (1998) 1.82

Mucormycosis in patients with haematological malignancies: a retrospective clinical study of 37 cases. GIMEMA Infection Program (Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto). Br J Haematol (1997) 1.77

Identification and antibiotic susceptibility of coagulase negative staphylococci isolated in corneal/external infections. Br J Ophthalmol (1999) 1.73

ESCMID and ECMM joint guidelines on diagnosis and management of hyalohyphomycosis: Fusarium spp., Scedosporium spp. and others. Clin Microbiol Infect (2014) 1.70

Species identification of Aspergillus, Fusarium and Mucorales with direct surface analysis by matrix-assisted laser desorption ionization time-of-flight mass spectrometry. Clin Microbiol Infect (2011) 1.69

Brief report: disseminated mycobacteriosis caused by drug-resistant Mycobacterium triplex in a human immunodeficiency virus-infected patient during highly active antiretroviral therapy. Clin Infect Dis (2000) 1.65

Elevated levels of C-reactive protein at discharge in patients with unstable angina predict recurrent instability. Circulation (1999) 1.63

Functional analysis of E2F transcription factor. Methods Enzymol (1997) 1.59

Screening of JAK2 V617F mutation in multiple myeloma. Leukemia (2006) 1.59

The C807T/G873A polymorphism in the platelet glycoprotein Ia gene and the risk of acute coronary syndrome in the Italian population. Br J Haematol (2001) 1.57

Application of molecular methods for detection and transmission analysis of mycobacterium tuberculosis drug resistance in patients attending a reference hospital in Italy. J Infect Dis (1999) 1.56

Identification of Mycobacterium avium subsp. paratuberculosis in biopsy specimens from patients with Crohn's disease identified by in situ hybridization. J Clin Microbiol (2001) 1.53

Multicenter comparative evaluation of six commercial systems and the national committee for clinical laboratory standards m27-a broth microdilution method for fluconazole susceptibility testing of Candida species. J Clin Microbiol (2002) 1.51

Inhibition of hematopoiesis by competitive binding of transcription factor PU.1. Proc Natl Acad Sci U S A (1994) 1.51

Increased platelet-fibrinogen affinity in patients with myeloproliferative disorders. Blood (1988) 1.50

Hypermethylation of GpG islands in the promoter region of p15(INK4b) in acute promyelocytic leukemia represses p15(INK4b) expression and correlates with poor prognosis. Leukemia (2003) 1.49

BAALC, the human member of a novel mammalian neuroectoderm gene lineage, is implicated in hematopoiesis and acute leukemia. Proc Natl Acad Sci U S A (2001) 1.48

Evaluation of a nonradiometric system (BACTEC 9000 MB) for detection of mycobacteria in human clinical samples. J Clin Microbiol (1997) 1.48

Different risks of thrombosis in four coagulation defects associated with inherited thrombophilia: a study of 150 families. Blood (1998) 1.47

Susceptibility of Acanthamoeba castellanii to contact lens disinfecting solutions. Antimicrob Agents Chemother (1995) 1.46

Infections caused by filamentous fungi in patients with hematologic malignancies. A report of 391 cases by GIMEMA Infection Program. Haematologica (2001) 1.45

Role of the Rb/E2F pathway in cell growth control. J Cell Physiol (1997) 1.44

Routine use of PCR-reverse cross-blot hybridization assay for rapid identification of Mycobacterium species growing in liquid media. J Clin Microbiol (1998) 1.43

Depressed immune response to tetanus in children with vitamin A deficiency. J Nutr (1992) 1.43

Generation of multinuclear tartrate-resistant acid phosphatase positive osteoclasts in liquid culture of purified human peripheral blood CD34+ progenitors. Br J Haematol (1997) 1.42

Autologous graft-versus-host disease after CD34+-purified autologous peripheral blood progenitor cell transplantation. J Hematother Stem Cell Res (2000) 1.41

Serum bilirubin levels at 72 hours by selected characteristics in breastfed and formula-fed term infants delivered by cesarean section. Acta Paediatr (2001) 1.40

Facial cleanliness and risk of trachoma in families. Arch Ophthalmol (1991) 1.39

Mortality related to thrombosis in congenital antithrombin III deficiency. Lancet (1991) 1.39

Antithrombin III in patients with hepatocellular carcinoma. Thromb Haemost (1987) 1.39

The incidence of secondary leukemias. Haematologica (1999) 1.36

Human herpesvirus 8 in Italian HIV-seronegative patients with Kaposi sarcoma. Arch Dermatol (1998) 1.36

ESCMID and ECMM joint clinical guidelines for the diagnosis and management of systemic phaeohyphomycosis: diseases caused by black fungi. Clin Microbiol Infect (2014) 1.36

Glycopeptide resistance among coagulase-negative staphylococci that cause bacteremia: epidemiological and clinical findings from a case-control study. Clin Infect Dis (2001) 1.34

Complex transcriptional regulatory mechanisms control expression of the E2F3 locus. Mol Cell Biol (2000) 1.32

Epidemiology of factor V Leiden: clinical implications. Semin Thromb Hemost (1998) 1.31

Intestinal and bronchial cryptosporidiosis in an immunodeficient homosexual man. Ann Intern Med (1983) 1.31

Evaluation of matrix-assisted laser desorption ionization-time-of-flight mass spectrometry in comparison to rpoB gene sequencing for species identification of bloodstream infection staphylococcal isolates. Clin Microbiol Infect (2011) 1.29

Incidence of the JAK2 V617F mutation among patients with splanchnic or cerebral venous thrombosis and without overt chronic myeloproliferative disorders. J Thromb Haemost (2007) 1.28

Identification of various medically important Candida species in clinical specimens by PCR-restriction enzyme analysis. J Clin Microbiol (1997) 1.27

Influence of participation on mortality in a randomized trial of vitamin A prophylaxis. Am J Clin Nutr (1987) 1.27

Biochemical and biophysical characterization of the reovirus cell attachment protein sigma 1: evidence that it is a homotrimer. Virology (1991) 1.25

Guidelines for the management of vitiligo: the European Dermatology Forum consensus. Br J Dermatol (2012) 1.24

The risk of thrombosis in patients with acute leukemia: occurrence of thrombosis at diagnosis and during treatment. J Thromb Haemost (2005) 1.22

Acute megakaryoblastic leukemia: experience of GIMEMA trials. Leukemia (2002) 1.22

Dissection of human humoral immune response against hepatitis C virus E2 glycoprotein by repertoire cloning and generation of recombinant Fab fragments. Hepatology (1998) 1.21

A and B postaxial polydactyly in two members of the same family. Clin Genet (1980) 1.20

Comparison of the mycobacteria growth indicator tube with radiometric and solid culture for isolation of mycobacteria from clinical specimens and susceptibility testing of Mycobacterium tuberculosis. New Microbiol (2000) 1.20

Transient ectopic expression of PTEN in thyroid cancer cell lines induces cell cycle arrest and cell type-dependent cell death. Hum Mol Genet (2001) 1.20

Mapping B-cell epitopes of hepatitis C virus E2 glycoprotein using human monoclonal antibodies from phage display libraries. J Virol (2001) 1.19

Retrospective study of candidemia in patients with hematological malignancies. Clinical features, risk factors and outcome of 76 episodes. Eur J Haematol (1999) 1.19